Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact. Objectives: ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Through the Medicare Advantage Value-Based Insurance Design (VBID) ...

Patients with chronic kidney disease (CKD) stages 3b or 4 experienced slower decline in estimated glomerular filtration rate 20 months after enrollment in a value-based kidney care program. Objectives ...

Prior authorization has been a flashpoint for providers, and, while insurers have taken steps to ease these utilization management protocols, they still play a key role as the industry shifts to value ...

About the Author: Ian Chiang is a principal at Flare Capital Partners, a healthcare technology and services-focused VC firm. Prior to joining Flare, he was the SVP of product and innovation and a ...

As healthcare leaders look to the year ahead, many predict that this will be the year the training wheels come off value-based care. This is not a new priority, but the move from value-based theory to ...

Precision Value Based Management owns the technology that grades and ranks physicians for payers, hospital systems, and ACOs, with over 21 million patients that are being tracked. “They know exactly ...

Business students need only three well taught courses: How to Value a Business, How to Think About Market Prices, and How to Manage a Business.—Inspired by Warren E. Buffett 2 A great deal has been ...

Even before COVID-19, health systems were experiencing reduced fee-for-service margins. In 2019, median Medicare margin nationally decreased 2.2 percent while hospital costs rose 2.5 percent per year.